ObjectiveTo explore the value of the treatment of Chloropidogrel Sulfate combined Aspirin in patients with stable angina pectoris.Methods200 patients with stable angina treated in our hospital from March 10,2015 to August 30,2016 were selected as subjects and were devided into two groups according to the patient treatment plan,100 cases in each group.Patients in the control group received Aspirin treatment on the basis of routine treatment such as Atorvastatin and Betalogram,while patients in the experimental group were treated with Aspirin and Chloropidogrel Sulfate.The clinical efficacy,the occurrence of adverse reactions,the number of angina pectoris onset,the duration of the attack and fibrinogen level were compared.ResultsThe total effective treatment rate in the experimental group (94.00%)was significantly higher than that in the control group(84.00%),and the difference was statistically significant(P＜0.05).After treatment,the number of angina pectoris onset of patients in the two groups were less than before treatment,the duration of the attack were shorter than before treatment,at the same time,the number of angina pectoris onset of patients in the experimental was less than that in the control group,the duration of the attack was shorter than that in the control group,the fibrinogen levels was lower than that in the control group,the differences were statistically significant(P＜0.05).There was no statistically significant difference of the occurrence of adverse reactions between the two groups(P＞0.05).ConclusionIt is significant that patients with stable angina pectoris should be treated with Chloropidogrel Sulfate combined with Aspirin to improve the curative effect and the cardiac function of patients.It is of great significance and is worthy of clinical application.